// App-Quantinova.ai

13832 : Lysophosphatidylcholine Derived From Lp-PLA2 Promotes the Mineralization of the Aortic Valve

Researchers

Presenter

  • Marie-Chloe Boulanger

Principal Investigators

  • Diala El Husseini

  • Dominique Fournier

  • Rihab Bouchareb

  • Jean-Pierre Despres

  • Philippe Pibarot

  • Yohan Bosse

  • Patrick Mathieu

Medical Centers

  • CRIUSMQ, Quebec, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Calcific Aortic Valve Disease

Biomarkers

  • Enzyme lipoprotein-associated phospholipase A2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim